and progression (5, 6) . It is likely that heritable genetic factors Email: i.campbell@pmci.unimelb.edu.au also contribute to the development of endometriosis (7) (8) (9) . In It is likely that heritable genetic factors contribute to the the cancer field many genes are now being investigated as development of endometriosis, which is a putative precursor potential low penetrance predisposing genes (10) and some of of the endometrioid and clear cell histological subtypes of these are now being investigated in endometriosis. The phase ovarian cancer. The phase II glutathione S-transferases II glutathione S-transferases (GSTs) are a family of enzymes (GSTs) are a family of enzymes responsible for metabolism responsible for the metabolism of a broad range of xenobiotics of a broad range of xenobiotics and carcinogens. Allelic and carcinogens. It has been proposed that GSTM1 is critical variants of GSTs that have impaired detoxification function in the detoxification of the products of oxidative stress produced may increase the rate of genetic damage and thereby during repair of the ovarian epithelium following follicle increase the susceptibility to cancer. The null genetic rupture. Failure to detoxify these products may result in rapid polymorphism in the gene encoding the GST class µ accumulation of genetic damage and increase susceptibility to (GSTM1) enzyme has been reported to be significantly epithelial ovarian cancer. A similar model could be proposed elevated in endometriosis patients and may represent for endometriosis, since it is characterized by cyclical degeneraan endometriosis susceptibility allele. In this study the tion and chronic inflamation, conditions which will result in frequency of the GSTM1 null genotype was investigated in production of reactive oxygen species. An elevated frequency 84 cases of endometriosis, 293 cases of ovarian cancer and of the inactive variant of the GSTM1 gene has recently been 219 controls. All cases and controls were derived from reported in endometriosis patients from Russia, Ukraine and women resident in the south east of England. The frequency France (11-13). In particular, Baranova et al. (12) observed a of the GSTM1 null allele was not over-represented in the highly significant excess of the GSTM null genotype among endometriosis patients (47.6%) compared with the controls French women with endometriosis compared with controls, (48.9%) (P ⍧ 0.898). In the ovarian cancer group the suggesting that defects in carcinogen detoxification may be GSTM1 null genotype was significantly elevated compared involved in the pathogenesis of this disease. Although very with controls (59.0 versus 48.9%, P ⍧ 0.025). When interesting, this conclusion was based on a small number of stratified according to histological subtype a significantly cases and needs to be interpreted cautiously. increased GSTM1 null genotype was only observed for In ovarian cancer only two studies have investigated the the endometrioid (65.4%, P ⍧ 0.013) and the combined GSTM1 null polymorphism and neither observed any significant endometrioid/clear cell ovarian cancers (67.0%, P ⍧ associations, but again the size of each study was small (14,15).
0.004). We conclude that the GSTM1 null allele is not
In addition, neither study investigated with any rigour potential an endometriosis susceptibility allele, however, it may differences in GSTM1 genotype frequencies with respect to predispose endometriotic lesions to malignant transhistological subtype. This is an important consideration, as formation to endometrioid and clear cell ovarian cancer.
there is good evidence to suggest that the different histological subtypes of ovarian cancer arise via distinct pathways (16,17). In particular, the endometrioid and clear cell subtypes probably Introduction arise via malignant transformation of endometriosis and not the ovarian surface epithelium (6) . Consequently, if the GSTM1 Endometriosis is defined as a condition in which tissue null allele represents an endometriosis predisposing allele then histologically similar to endometrium is found at sites outside it should also be over-represented among endometrioid and the uterine cavity. The aetiology of endometriosis is uncertain, clear cell ovarian cancers. but implantation of viable endometrium refluxed into the The aim of this study was to assess the risk of endometriosis peritoneal cavity during menstruation is the most widely and ovarian cancer associated with the GSTM1 null polyinvoked theory to explain its origin (1) . Very little is known morphism and to investigate possible associations with about the underlying mechanisms that lead to the development histological subtypes of ovarian cancer. of endometriosis, which is remarkable given that it is one of the most common gynaecological diseases that may affect
Materials and methods

Subjects
Details of cases and controls have been described previously (18-20). Incident Abbreviations: CI, confidence interval; GST, glutathione S-transferase; OR, odds ratio.
cases of ovarian tumours and endometriosis were ascertained from women S.W.Baxter, E.J.Thomas and I.G.Campbell frequency of the GSTM1 null genotype among the combined
The primers used for GSTM1 were G1 (5Ј-ctgccctacttgattgatggg-3Ј) and G2 (5Ј-ctggattgtagcagatcatgc-3Ј), which amplify a 271 bp product in non-null clear cell and endometrioid types was 67%, which was highly homozygotes and non-null heterozygotes but not in null homozygotes (11). statistically significant (P ϭ 0.004). The frequency of the null To confirm successful amplification an internal control was included in each genotype among the serous subgroups was also high compared PCR reaction, which consisted of a primer set which amplifies a 201 bp with the controls (57.5 versus 48.9%), but this failed to reach polymorphic exonic CAG microsatellite in the AIB1 gene (22) . PCR was carried out in a reaction volume of 10 µl containing 10-200 ng genomic statistical significance (P ϭ 0.147). the GSTM1 null genotype in French women with endometriosis Reaction products were resolved on 2% agarose gels.
versus controls (76.9 versus 45.8%, P ϭ 0.0001) and concluded
Statistical analysis
that the GSTM1 null allele represents a predisposing factor for Comparisons of frequency were analysed using Fisher's exact test.
endometriosis. However, this conclusion was based on only 65 cases and 72 controls. Our study of 84 endometriosis cases Results and 219 controls does not provide any support for the assertion that the GSTM1 null allele is a predisposing factor for GSTM1 null genotyping performed by multiplex PCR enabled the precise discrimination of individuals homozygous for the endometriosis. Although our study is only slightly larger than that reported by Baranova et al., we did not observe any null allele. In order to reduce the possibility of recording a false GSTM1 null genotype the PCR conditions were optimized excess of the GSTM1 null genotype among the endometriosis cases and, indeed, the frequency was lower than in the controls. so that amplification was biased towards the GSTM1 gene fragment as illustrated in Figure 1 . Over 100 samples were Consequently, we believe that the GSTM1 null genotype is unlikely to represent a significant risk factor for endometriosis. genotyped twice in independent experiments to assess the consistency of the assay and in no case was a discrepancy Nevertheless, this will need verification from additional independent studies. observed. Table I shows the GSTM1 null genotype frequency among 84 cases of endometriosis, 293 cases of ovarian cancer
We observed a significant elevation in the GSTM1 null genotype among 293 ovarian cancers, which is in contrast to and 219 controls. The GSTM1 null genotype frequency of 48.9% among the controls is consistent with previous reported two previous studies (14,15) which failed to detect any significant association. However, both of these studies were Caucasian control populations (10). The GSTM1 null genotype among the endometriosis cases was not significantly different lacking in statistical power since they involved only 84 cases and 325 controls (14) and 103 patients and 115 controls (15). from the controls (P ϭ 0.898). However, because of the relatively small number of cases we had only a 30% power to
In addition, our analysis with respect to histological subtype revealed that the high frequency of GSTM1 null genotypes detect an odds ratio (OR) of 1.5 at a significance level of 0.05. Among the ovarian cancers as a whole the GSTM1 null was predominantly due to a highly significant excess among the endometrioid and clear cell subtypes [P ϭ 0.004, OR genotype was significantly higher than the controls (59.0 versus 48.6%, P ϭ 0.025). Stratifying the ovarian cancers with respect 2.14, 95% confidence interval (CI) 1.28-3.55]. The two previous studies did not specifically address histological subto histological subtype revealed that only the endometrioid subtype had a significantly increased frequency of the GSTM1 
